Skip to content

News

News

Regulatory decisions, trial readouts and developments in peptide research, reported with the evidence attached.

CLINICAL

Retatrutide Phase 3: What the TRIUMPH-1 Results Show

Sponsor-reported Phase 3 results put retatrutide's mean weight reduction above any published figure for a drug. Here is what was measured, what was not, and what still has to happen.

3 min read

The Peptide Insider newsletter

Stay Inside Peptide Research

Get important peptide research, clinical trial updates, regulatory developments, and new Peptide Insider guides delivered to your inbox.

The Peptide Insider newsletter is not open for signups yet. Configure NEXT_PUBLIC_NEWSLETTER_ENDPOINT to enable it.